NCT01214993: A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects |
|
|
| Completed | 1 | 38 | US | GSK1349572, Placebo, Iohexol Injection, OMNIPAQUE, Para-aminohippurate infusion | ViiV Healthcare, Shionogi, GlaxoSmithKline | Infections, Human Immunodeficiency Virus and Tuberculosis | 11/10 | 11/10 | | |
